Analysis of real-world treatment patterns in patients with prurigo nodularis - 11/12/19
Doi : 10.1016/j.jaad.2019.09.007
Amy H. Huang, MPH a, b, Joseph K. Canner, MHS c, Sewon Kang, MD, MPH a, Shawn G. Kwatra, MD a, b, ⁎ 
a Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland
b Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland
c Johns Hopkins Surgery Center for Outcomes Research, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
∗Correspondence to: Shawn G. Kwatra, MD, Cancer Research Building II, Johns Hopkins University School of Medicine, Ste 206, 1550 Orleans St, Baltimore, MD 21231Cancer Research Building IIJohns Hopkins University School of MedicineSte 2061550 Orleans StBaltimoreMD21231
| Funding sources: Dr Kwatra received grant funding from the Skin of Color Society and is a recipient of the Dermatology Foundation Medical Dermatology Career Development Award. |
|
| Disclosure: Dr Kwatra is an advisory board member for Menlo and Trevi Therapeutics and has received grant funding from Kiniksa Pharmaceuticals. Dr Kang is a consultant for Menlo Therapeutics and an advisory board member for Unilever. Ms Huang and Mr Canner have no conflicts of interest to declare. |
|
| Reprints not available from the authors. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 1
P. 34-36 - janvier 2020 Retour au numéro
Article précédent
- Shifting from expectant observation to active intervention
- Warren R. Heymann
- Serial biologic therapies in psoriasis patients: A 12-year, single-center, retrospective observational study
- Emanuele Cozzani, Yiran Wei, Martina Burlando, Alessio Signori, Aurora Parodi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?